Abbott Afinion 2 Analyzer

Abbott has launched the Afinion 2 analyzer, a new generation of its Afinion system, in the US. The Afinion 2 provides patients with health information that they can discuss with their providers during a single visit, Abbott said. It is a compact rapid, multi-assay platform that streamlines and simplifies the delivery of results at the point of care for measurements of hemoglobin A1c (HbA1c) and albumin-to-creatinine ratio (ACR), the firm said. Healthcare professionals receive results in three minutes for HbA1c and five minutes for ACR, and can thus dedicate more time to counseling patients within a single office visit, Abbott said. The new analyzer is already available with HbA1c, ACR, C-reactive protein, and a lipid panel in select markets outside the US.